lung cancer

News

Latest lung cancer data could open new avenue for Roche's Te...

Roche is eyeing a new use for its checkpoint inhibitor immunotherapy Tecentriq after it posted results showing it extended patients’ lives by an extra two months compared with chemotherapy

News

AZ grabs EU approval for Imfinzi in advanced lung cancer

The European Commission has approved AstraZeneca’s immunotherapy drug Imfinzi (durvalumab) in a kind of lung cancer that was previously only treatable with chemotherapy.

News

AstraZeneca gets further approval for Tagrisso in Japan

AstraZeneca received approval from the Japanese regulator following a priority review of Tagrisso (osimertinib) as a first-line treatment of patients with positive non-small cell lung cance

News

Roche’s Alecensa fast-tracked in China

China's national regulator has granted a rapid approval for Roche’s lung cancer treatment Alecensa just months after European and American approvals, following a revamp of the country's not

Market Access

NICE okays Roche rare lung cancer drug after price cut

Alecensa has aced Pfizer's rival in head-to-head trial

News

AZ’s Tagrisso wins new NSCLC first-line approval in Europe

AstraZeneca has widened the licence for its cancer drug Tagrisso (osimertinib) in Europe after regulators gave it the green-light for first-line use against additional types of non-small ce

Latest lung cancer data could open new avenue for Roche's Te...

AZ grabs EU approval for Imfinzi in advanced lung cancer

AstraZeneca gets further approval for Tagrisso in Japan

Roche’s Alecensa fast-tracked in China

NICE okays Roche rare lung cancer drug after price cut

AZ’s Tagrisso wins new NSCLC first-line approval in Europe

Ipsen' Bylvay fluffs its lines in biliary atresia trial

Discover a new era of healthcare panel engagement: Grounded ...

lung cancer

Editor's Picks